Worcester, MA – Michael D. West, Ph.D., President and Chief Scientific Officer of Advanced Cell Technology, Inc. (OTC Bulletin Board: ACTC.OB) will present, “Human Embryonic Stem Cells and Nuclear Transfer: Opportunities and Challenges,” at the Strategies for Engineered Negligible Senescence (SENS) conference today, Friday, September 9, 2005, at Queen’s College in Cambridge, England.
Dr. West will describe ACT’s efforts to address the challenges of translating the opportunity of human embryonic stem cell and nuclear transfer technology into new therapeutic products, with a focus on age-related degenerative diseases.
“This is an excellent opportunity for us to come together with a diverse group of experts, from academia and industry in the field of regenerative medicine, from all over the world,” said William Caldwell, Chief Executive Officer of Advanced Cell Technology.
Conference information can be found at http://www.gen.cam.ac.uk/sens2/index.html.
Advanced Cell Technology, Inc., a Nevada corporation, is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts. For more information about the company visit http://www.advancedcell.com
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and its subsidiary, Advanced Cell, Inc., and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2005.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.